Aquestive Therapeutics, Inc. (AQST) Profit Margins
Over the twelve months to 2026-06-30, Aquestive Therapeutics, Inc. (AQST) had gross margin 67.0%, operating margin -97.5%, net margin -144.6%, free cash flow margin -85.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AQSTAquestive Therapeutics, Inc.Follow AQST — free
—
Price chart with a free account
- Market cap
- 502.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 71.7% | — | 59.3% | 58.8% | 69.0% | 58.3% | 67.0% | |
| Operating margin | -72.6% | -100.1% | -93.6% | -68.2% | -88.2% | -29.9% | -53.5% | -159.5% | -97.5% | |
| Net margin | -91.0% | -125.9% | -121.7% | -138.8% | -114.1% | -15.6% | -76.7% | -188.1% | -144.6% | |
| FCF margin | -22.0% | -115.7% | -100.3% | -66.7% | -22.7% | -14.6% | -62.4% | -119.0% | -85.0% |
USD millions · SEC XBRL
Aquestive Therapeutics, Inc. — questions
- What is Aquestive Therapeutics, Inc.'s gross margin?
- 67.0% over the twelve months to 2026-06-30.
- What is Aquestive Therapeutics, Inc.'s operating margin?
- -97.5% over the twelve months to 2026-06-30.
- What is Aquestive Therapeutics, Inc.'s net profit margin?
- -144.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Aquestive Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.